Tusk Therapeutics to be Acquired by Roche

STEVENAGE, United Kingdom, Sept. 28 (Korea Bizwire) - Tusk Therapeutics Ltd (“Tusk”) was today acquired by Roche. Tusk has developed an antibody with a novel mode of action aimed at depleting regulatory T-cells (Tregs). Tregs suppress immune responses, including those against cancer cells. Preclinical data has shown that depleting Tregs from the tumor microenvironment can enhance [...]